Tenaya Therapeutics, Inc. (TNYA) — Dilution Risk Analysis

Current Snapshot

Tenaya Therapeutics, Inc. (TNYA) has a DilutionWatch score of 45/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
224,230,012 Source
Public Float
216,072,291 Source
Float as % of Outstanding
96.4%

Dilution Risk Score

Score: 45/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 4 9, 8-K 1.

FormFiledAccession
4 2026-02-26 0001193125-26-076814
4 2026-02-24 0001193125-26-067007
4 2026-02-17 0001193125-26-055439
4 2026-02-17 0001193125-26-055442
4 2026-02-17 0001193125-26-055445
4 2026-02-12 0001193125-26-049028
4 2026-02-05 0001193125-26-039760
4 2026-02-05 0001193125-26-039763
4 2026-02-05 0001193125-26-039768
8-K 2026-01-30 0001193125-26-032017

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $60,000,000 Source
Cash runway 10 months Source
Three-year share count growth 229.21% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 45/10) Source
Cash Runway
10 months Source
ATM Offering Capacity Remaining
$60,000,000 Source
Share Count Growth (3-Year)
229.21% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.